Is BMI a Good Measure of Health?

A physician's balanced look at what BMI can and cannot tell you about a single person's health.

Is BMI a good measure of health? BMI is a useful screening number, not a diagnosis. It reliably flags weight-related risk across large populations, which is why clinicians and researchers still use it. For an individual, it is a rough first look. It cannot see muscle, fat location, or how a body actually functions, so it works best as one reading among several.

What is BMI, and why do doctors use it at all?

Body mass index is your weight in kilograms divided by your height in meters squared. That is the whole formula. It was never meant to judge a single person. It was built in the 1800s to describe patterns across groups, and it stuck around because it is cheap, fast, and needs only a scale and a tape measure on the wall.

In my clinic I still record it at every visit. Not because it tells me who you are, but because it gives me a shared starting point and a number I can track over time. When something is easy to measure and roughly correlates with risk, it earns a place in the workflow. BMI earns its place. It just does not deserve the last word.

Where does BMI actually work well?

At the population level, BMI does its job. Across thousands of people, higher categories track with higher rates of type 2 diabetes, high blood pressure, fatty liver, sleep apnea, and cardiovascular disease. Public health researchers can look at a whole city and estimate metabolic risk without examining anyone individually. That is genuinely valuable, and it is the context the tool was designed for.

It also gives a reasonable first signal for many people in the middle of the range. If your BMI is well into the obesity category and you carry weight around the middle, the number and the mirror usually agree. In those cases BMI is a fair opening question, and it points toward the same conversation a more detailed workup would.

Where does BMI fail an individual person?

Here is where I ask patients not to over-read it. BMI cannot tell muscle from fat. A strong, active person with real muscle mass can land in the overweight or even obese category while being metabolically healthy. Meanwhile someone with a normal BMI can carry excess visceral fat, the deep fat wrapped around the organs, and quietly run higher risk than the number suggests.

Fat distribution matters more than total mass, and BMI is blind to it. Weight around the waist behaves very differently from weight on the hips and thighs. The formula treats them as identical.

Ethnicity complicates it further. The standard cutoffs were derived largely from populations of European descent, and they do not fit everyone equally. People of South Asian and several East Asian backgrounds, for example, can develop metabolic problems at lower BMI values, which is why lower thresholds are often used for those groups. A single set of lines drawn on a chart cannot capture that range of human bodies.

Age and sex shift the picture too. Older adults lose muscle and gain fat while the number on the chart barely moves. Two people at the same BMI can be in very different metabolic situations.

What measures fill in what BMI misses?

This is the practical part. A few simple additions make the picture much sharper, and none require fancy equipment.

• Waist circumference. A tape measure around the middle estimates the abdominal fat that drives much of the metabolic risk. Paired with BMI, it catches many people the number alone would miss.
• Waist-to-height ratio. Keeping your waist under half your height is a rough, sensible target that travels well across body types.
• Lab work. Fasting glucose, hemoglobin A1c, a lipid panel, blood pressure, and liver enzymes describe how the body is functioning, not just how much it weighs.
• Body composition. Where available, tools that separate fat from lean mass answer the muscle-versus-fat question BMI cannot.

None of these is perfect either. Waist measurement depends on where the tape sits and who is holding it. The point is not to crown a new single number. The point is that several modest readings together beat any one of them alone.

How should a clinician actually use BMI?

As a triage step, then a conversation. I use BMI to decide how closely to look, not to decide what is true. If it is elevated, I reach for the waist tape and the labs. If it is normal but the waist or the bloodwork is off, I trust the body over the chart. A number that flags a question is doing exactly what it should. A number treated as a verdict is being asked to do a job it was never built for.

This matters for treatment decisions too. The medications we work with, including compounded semaglutide and tirzepatide, are considered for people based on the whole clinical picture and health risk, not a single index. Those compounded formulations are not FDA-approved and are not identical to the brand versions, and results vary by individual. The clinical reasoning behind offering them rests on function and risk, which is exactly why BMI alone was never enough to make that call.

Is the field changing how it measures obesity?

Yes, and it is a healthy conversation rather than a revolt. A growing body of expert opinion argues for defining obesity by health, not just by an index, distinguishing weight that is already harming organs and function from weight that is a risk marker without current disease. That kind of nuance moves the field toward measuring how a body works rather than only what it weighs.

I read this as refinement, not rejection. BMI is not being thrown out. It is being put back in its proper place, as a screening entry point that hands off to better tools once the door is open. That is how good measures are supposed to age. They get context, not contempt.

What is the practical takeaway?

If you remember one thing, make it this. Your BMI is a starting line, not a scorecard. Use it to decide whether to look closer, then look closer. Ask for your waist measurement. Ask what your labs say. Notice whether you are strong or deconditioned, where you carry weight, and how you actually feel and function day to day.

A single number can open a useful conversation. It should never end one. The bodies I see in practice are far more interesting, and far more informative, than any chart. If your weight or your metabolic numbers are on your mind, the most useful next step is a real evaluation that treats you as a whole person rather than a point on a graph.

Trademark note: Ozempic and Wegovy are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly. New Hope Weight Loss and Wellness is not affiliated with or endorsed by these companies.

Frequently asked questions

This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.